Mizuho Securities USA’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mizuho Securities USA’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-168,101	Closed	-$2.6M	–	131
2018 Q3	$2.6M	Sell	168,101 -36,073	-18%	-$570K	0.2%	54
2018 Q2	$3.27M	Buy	+204,174	New	+$3.02M	0.33%	58
2017 Q1	–	Sell	-29,850	Closed	-$382K	–	203
2016 Q4	$382K	Sell	29,850 -8,955	-23%	-$113K	0.02%	172
2016 Q3	$516K	Buy	+38,805	New	+$454K	0.04%	147
2016 Q2	–	Sell	-28,059	Closed	-$257K	–	207
2016 Q1	$257K	Buy	+28,059	New	+$231K	0.06%	91
2013 Q3	–	Sell	-11,940	Closed	-$100K	–	145
2013 Q2	$100K	Buy	+11,940	New	+$145K	﹤0.01%	143

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mizuho Securities USA's IRWD Position: Q4 2018 in Review

Mizuho Securities USA sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2018, closing a stake of 168,101 shares — an estimated $2.6M sold.

Mizuho Securities USA first reported a position in IRWD in Q2 2013 and held it in 6 quarters. The position peaked at $3.27M in Q2 2018. 145 funds tracked by Wall St. Rank hold IRWD as of Q4 2018.

Mizuho Securities USA reported no remaining Ironwood Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Mizuho Securities USA sold 168,101 Ironwood Pharmaceuticals shares in Q4 2018, an estimated $2.6M.
Mizuho Securities USA first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Mizuho Securities USA's Ironwood Pharmaceuticals position peaked at $3.27M in Q2 2018.
145 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2018.

Based on Mizuho Securities USA's 13F filing for Q4 2018, filed 4 Feb 2019.